Ala Altaie: We Found That Mononuclear Cells From RA Patients Can Trigger Clot Formation
Ala Altaie, Research Fellow in Mesenchymal Stem Cell Biology at the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, shared a post on LinkedIn:
”New paper out!
Why do some patients on JAK inhibitors develop venous thromboembolism (VTE) or pulmonary embolism (PE) without deep vein thrombosis?
In our latest study led by Paula David and colleagues, we found that mononuclear cells from RA patients can trigger clot formation—especially when exposed to JAK inhibitors like tofacitinib.
This process, known as immunothrombosis, links the immune system to coagulation through increased Factor III production.
Panel A: Clots formed faster with tofacitinib
Panel B: Clot strength was higher
These findings shed light on the immune–coagulation connection behind JAK inhibitor–associated clots.
Read more.”
Title: Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritis
Authors: Paula David, Tom Macleod, Ala Altaie, Yu Shi, Kerem Abacar, Sami Giryes, Gabrielle de Mello Santos, Payal Ganguly, Mark Harland, Chi Wong, Andrew Scarsbrook, Paul Emery, Kulveer Mankia, Shouvik Dass, Andrea Di Matteo, Benazir Saleem, Cédric Duval, Robert Ariëns, Dennis McGonagle
Stay updated with Hemostasis Today.
-
Feb 25, 2026, 16:47Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
-
Feb 25, 2026, 16:40Mohammed Almohammadi: Uniting Leaders in Laboratory Hematology at the 1st Saudi ISLH Joint Conference
-
Feb 25, 2026, 16:37Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
-
Feb 25, 2026, 16:34Michael Makris: Biomarin Has Decided to Withdraw Roctavian from the Market
-
Feb 25, 2026, 16:25Tagreed Alkaltham: The Blood Banker Personality
-
Feb 25, 2026, 16:17Sanjay Ahuja: Insightful Talk on 100 Years of VWD by Jorge Di Paola
-
Feb 25, 2026, 15:20Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
-
Feb 25, 2026, 15:15Ajay Kumar: Plasma Component Quality Control Standards
-
Feb 25, 2026, 15:09Wolfgang Miesbach: Efficacy, Safety and Thrombosis Signals in Haemophilia A/B with Inhibitors